title: Legal and regulatory considerations associated with use of patient-generated health data from social media and mobile health (mHealth) devices.
abstract: Patient-generated health data are coming into broader use across the health care spectrum and hold great promise as a means to improve care and health outcomes. At the same time, rapid evolution in the social media and mobile health (mHealth) market has promoted an environment in which creation and transmission of personal health information is easy, quick, and appealing to patients. However, adoption of social media and mHealth by providers is hampered by legal and regulatory concerns with regard to data ownership and data use. This article defines common forms of patient-generated health data (PGHD) and describes how PGHD is used in clinical settings. It explores issues related to protection of personal health information, including that of children and adolescents, data security, and other potential barriers such as physician licensure. It also discusses regulatory and legal considerations providers and patients should consider before using social media and mobile health apps.
authors.affiliation: Mayo Clinic , Rochester, Minnesota, USA.
authors.forename: C
authors.initials: C
authors.lastname: Petersen
authors.affiliation: Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University , Portland, Oregon, USA ; Schwabe, Williamson & Wyatt , Seattle, Washington, USA.
authors.forename: P
authors.initials: P
authors.lastname: DeMuro
mesh_terms: D063005:Health Information Systems / Q000331:legislation & jurisprudence*; D006801:Humans; D010067:Ownership; D012926:Social Control, Formal; D061108:Social Media; D017216:Telemedicine / Q000295:instrumentation*
keywords: Social media; jurisprudence; legislation; mobile apps; mobile health; patient outcome assessment
references.citation: Nat Biotechnol. 2011 May;29(5):411-4
references.pmid: 21516084
references.citation: J Am Coll Surg. 2013 Oct;217(4):648-55
references.pmid: 23891066
references.citation: J Gen Intern Med. 2001 Nov;16(11):785-6
references.pmid: 11722694
references.citation: Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):447-53
references.pmid: 21831026
references.citation: Med Care. 1988 Mar;26(3):307-14
references.pmid: 3352327
references.citation: Clin Pharmacol Ther. 2014 Aug;96(2):239-46
references.pmid: 24713590
references.citation: JAMA. 1989 Aug 18;262(7):907-13
references.pmid: 2754790
references.citation: BMJ. 2013;346:f2614
references.pmid: 23674136
references.citation: N Engl J Med. 2013 Aug 1;369(5):397-400
references.pmid: 23822654
references.citation: Clin Pharmacol Ther. 2012 Jun;91(6):1010-21
references.pmid: 22549283
references.citation: J Gen Intern Med. 2012 May;27(5):520-6
references.pmid: 22127797
references.citation: Health Aff (Millwood). 2013 Feb;32(2):202
references.pmid: 23381509
references.citation: J Pain Symptom Manage. 2009 Jun;37(6):1027-38
references.pmid: 19394793
references.citation: Eur J Clin Pharmacol. 2010 Nov;66(11):1143-50
references.pmid: 20658130
references.citation: Health Qual Life Outcomes. 2006;4:79
references.pmid: 17034633
references.citation: Br J Clin Pharmacol. 2011 Nov;72(5):806-22
references.pmid: 21496066
references.citation: Med Care. 2010 Jun;48(6 Suppl):S32-8
references.pmid: 20473201
references.citation: J Particip Med. 2011 Jul 10;3:null
references.pmid: 21853160
references.citation: JMIR Mhealth Uhealth. 2014 May 08;2(2):e21
references.pmid: 25099368
references.citation: Biomed J. 2014 Mar-Apr;37(2):71-7
references.pmid: 24732661
references.citation: Telemed J E Health. 2011 Oct;17(8):652-5
references.pmid: 21790270
references.citation: J Am Med Inform Assoc. 2015 Apr;22(e1):e28-33
references.pmid: 25147247
references.citation: J Adolesc Health. 2012 Nov;51(5):409-14
references.pmid: 23084160
references.citation: J Clin Oncol. 2007 Jun 1;25(16):2329-30
references.pmid: 17538182